Westpac Banking Corp Guardant Health, Inc. Transaction History

Westpac Banking Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$88.71 - $120.43 $5.39 Million - $7.32 Million	-60,815 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$98.77 - $132.17 $286,433 - $383,292	-2,900 Reduced 4.55%	60,815 $7.6 Million
Q2 2021 Aug 11, 2021	BUY	$109.77 - $165.68 $2.4 Million - $3.63 Million	21,900 Added 52.37%	63,715 $7.91 Million
Q1 2021 May 13, 2021	SELL	$127.04 - $179.1 $1.61 Million - $2.27 Million	-12,696 Reduced 23.29%	41,815 $6.38 Million
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $5.45 Million - $7.41 Million	54,511 New	54,511 $7.03 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.56B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

Stay updated on Westpac Banking Corp with notifications on news.